Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation

Completed · Phase 4

Conditions studied: Kidney Transplantation

In brief

A prospective, single center, open-label, randomized trial of Thymoglobulin induction and sirolimus, prednisone, and mycophenolate mofetil versus Thymoglobulin induction and tacrolimus, prednisone, and mycophenolate mofetil in non-HLA identical living or deceased donor kidney transplant recipients.

Key facts

Study ID

NCT00305396

Run by

Vanderbilt University

People needed

80

Starts

2004-04-01

Expected to finish

2005-03-01

Last updated by the study team

2006-03-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary cadaver or non-HLA identical living donor kidney transplant. -

You may not qualify if…

• HIV HCV Pregnancy Age < 18 years Malignancy

Where it is running

• Vanderbilt University Medical Center/Nashville VA — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.